Horan Capital Management Has Decreased By $319,104 Its Cvs Health (CVS) Holding; NOVATEK JT STK CO SPONSORED GDR REG S R (NOVKY) Sellers Decreased By 27.44% Their Shorts

May 21, 2018 - By Migdalia James


Horan Capital Management decreased Cvs Health Corp (CVS) stake by 3.78% reported in 2017Q4 SEC filing. Horan Capital Management sold 4,432 shares as Cvs Health Corp (CVS)’s stock declined 17.45%. The Horan Capital Management holds 112,681 shares with $8.17 million value, down from 117,113 last quarter. Cvs Health Corp now has $66.52 billion valuation. The stock increased 0.79% or $0.51 during the last trading session, reaching $65.43. About 1.33M shares traded. CVS Health Corporation (NYSE:CVS) has declined 22.81% since May 21, 2017 and is downtrending. It has underperformed by 34.36% the S&P500.

NOVATEK JT STK CO SPONSORED GDR REG S R (OTCMKTS:NOVKY) had a decrease of 27.44% in short interest. NOVKY’s SI was 43,100 shares in May as released by FINRA. Its down 27.44% from 59,400 shares previously. With 100 avg volume, 431 days are for NOVATEK JT STK CO SPONSORED GDR REG S R (OTCMKTS:NOVKY)’s short sellers to cover NOVKY’s short positions. The SI to NOVATEK JT STK CO SPONSORED GDR REG S R’s float is 0.02%. It closed at $129.9 lastly. It is down 0.00% since May 21, 2017 and is . It has underperformed by 11.55% the S&P500.

Among 2 analysts covering NovaTek (OTCMKTS:NOVKY), 0 have Buy rating, 0 Sell and 2 Hold. Therefore 0 are positive. NovaTek had 2 analyst reports since October 19, 2015 according to SRatingsIntel. The stock has “Neutral” rating by Goldman Sachs on Monday, October 19. The company was upgraded on Monday, January 30 by JP Morgan.

PAO NOVATEK, an independent oil and gas company, engages in the acquisition, exploration, development, production, processing, marketing, and export of natural gas and liquid hydrocarbons. The company has market cap of $39.17 billion. The firm principally holds interests in reserves located in the Yamal-Nenets Autonomous Region, Western Siberia. It has a 7.77 P/E ratio. The Company’s products include natural gas, stable gas condensate, liquefied petroleum gas, and crude gas and oil condensate refined products.

Among 26 analysts covering CVS Health (NYSE:CVS), 19 have Buy rating, 0 Sell and 7 Hold. Therefore 73% are positive. CVS Health had 77 analyst reports since July 22, 2015 according to SRatingsIntel. SunTrust maintained the shares of CVS in report on Thursday, January 4 with “Buy” rating. Oppenheimer maintained the stock with “Outperform” rating in Thursday, December 17 report. The company was maintained on Wednesday, November 9 by Mizuho. The rating was maintained by Mizuho with “Buy” on Thursday, June 23. The firm has “Overweight” rating given on Monday, November 2 by JP Morgan. The stock of CVS Health Corporation (NYSE:CVS) earned “Buy” rating by Oppenheimer on Wednesday, May 2. The stock of CVS Health Corporation (NYSE:CVS) earned “Outperform” rating by RBC Capital Markets on Wednesday, August 5. The rating was reinitiated by Evercore with “Buy” on Wednesday, August 19. SunTrust maintained it with “Buy” rating and $85.0 target in Friday, October 13 report. The rating was maintained by Leerink Swann on Monday, January 8 with “Buy”.

Analysts await CVS Health Corporation (NYSE:CVS) to report earnings on August, 14. They expect $1.61 earnings per share, up 21.05% or $0.28 from last year’s $1.33 per share. CVS’s profit will be $1.64 billion for 10.16 P/E if the $1.61 EPS becomes a reality. After $1.48 actual earnings per share reported by CVS Health Corporation for the previous quarter, Wall Street now forecasts 8.78% EPS growth.

Investors sentiment decreased to 0.72 in 2017 Q4. Its down 0.16, from 0.88 in 2017Q3. It turned negative, as 115 investors sold CVS shares while 600 reduced holdings. 134 funds opened positions while 380 raised stakes. 815.59 million shares or 1.76% more from 801.45 million shares in 2017Q3 were reported. Focused Invsts Limited Liability Company has invested 4.78% of its portfolio in CVS Health Corporation (NYSE:CVS). Earnest Prtn Lc invested in 0% or 467 shares. Lucus stated it has 4,573 shares. New York-based X Management Lc has invested 0.03% in CVS Health Corporation (NYSE:CVS). Kayne Anderson Rudnick Invest Ltd Liability Co has 55,454 shares for 0.03% of their portfolio. Edinburgh Prtn Ltd reported 335 shares. Price T Rowe Inc Md accumulated 15.09 million shares or 0.18% of the stock. The Kansas-based Creative Planning has invested 0.03% in CVS Health Corporation (NYSE:CVS). Washington Trust Co, a Rhode Island-based fund reported 216,023 shares. Bridgewater Associates LP invested in 420,695 shares or 0.25% of the stock. Nelson Roberts Inv Advisors Ltd Co has 0.12% invested in CVS Health Corporation (NYSE:CVS) for 5,434 shares. Veritas Investment Mgmt (Uk) Ltd holds 188,014 shares or 5.03% of its portfolio. Cambridge Tru has invested 0.06% in CVS Health Corporation (NYSE:CVS). Omers Administration has invested 0.02% in CVS Health Corporation (NYSE:CVS). Guardian Capital Advisors LP owns 4,235 shares or 0.04% of their US portfolio.

Since February 16, 2018, it had 2 insider purchases, and 1 sale for $713,454 activity. The insider BROWN C DAVID II bought 10,000 shares worth $619,900. DORMAN DAVID W had bought 24,300 shares worth $1.51 million on Friday, May 4. Foulkes Helena had sold 19,965 shares worth $1.42 million on Friday, February 16.

More notable recent CVS Health Corporation (NYSE:CVS) news were published by: Seekingalpha.com which released: “We Are Playing The CVS Hand” on May 11, 2018, also Seekingalpha.com with their article: “Trade Mistake 3: CVS Boredom Trade” published on May 09, 2018, Seekingalpha.com published: “CVS: Going Long, And Understanding The Aetna Deal” on April 30, 2018. More interesting news about CVS Health Corporation (NYSE:CVS) were released by: Fool.com and their article: “5 Things You’ll Want to Know About CVS Health’s Plans for 2018 and Beyond” published on May 04, 2018 as well as Seekingalpha.com‘s news article titled: “CVS Health: A Store-Level Look At The Proposed Healthcare Giant” with publication date: April 26, 2018.

CVS Health Corporation (NYSE:CVS) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.